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Background: Subjective Memory Complaints (SMC) along with cognitive deficits are frequently observed in pa-
tients with Major Depressive Disorder (MDD). The relationship between SMC and objective memory performance 
in patients with MDD was evaluated, in comparison with patients with Mild Cognitive Impairment due to Alz-
heimer’s Disease (MCI-AD) and healthy controls (HC). 
Methods: Patients with MDD (n = 47), MCI-AD (n = 43) and HC (n = 45) were assessed with a self-report memory 
complaints scale (SMCS) and underwent a comprehensive clinical and neuropsychological assessment. A 
discrepancy score between the Logical Memory delayed recall and the SMCS total score was calculated as a 
measure of memory awareness. 
Results: Patients with MDD (12.5 ± 4.4) and patients with MCI-AD (10.9 ± 4.1) had not significantly different 
SMCS total scores, whereas HC showed significantly lower scores (4.0 ± 3.0). As much as 74.5% of patients with 
MDD patients and 65.1% of patients with MCI-AD reported prominent memory complaints, whereas only 4.4% of 
HC did. Patients with MDD had relatively preserved memory tests, resulting in a higher discrepancy score than 
both patients with MCI-AD and HC. The SMCS total score correlated positively with depressive symptoms in the 3 
groups of participants. 
Conclusions: Patients with MDD showed inaccurate memory self-awareness as they under-estimated their memory 
functioning, a pattern distinct from both patients with MCI-AD and HC.   
1. Introduction 
Major Depressive Disorder (MDD) is a heterogeneous mental disease 
with high prevalence, affecting about 6% of the adult population 
worldwide each year (Otte et al., 2016). Changes in mood, motivation 
and affect are characteristic of MDD, but cognitive difficulties also 
represent a leading symptom (American Psychiatric Association, 2013). 
Slowing down of thought, diminished ability to think or concentrate and 
indecisiveness are included in the 5th edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) criteria for MDD 
(American Psychiatric Association, 2013). A systematic review and 
meta-analysis of 24 studies using the same battery of tests, the 
Cambridge Neuropsychological Test Automated Battery (CANTAB), 
indicated that patients with MDD show cognitive deficits in the domains 
of executive functions, attention, and memory. Interestingly, these 
cognitive deficits persist beyond symptoms of low mood, during 
remitted states of depression (Rock et al., 2014). In accordance with the 
presence of cognitive deficits, patients with MDD frequently refer sub-
jective memory complaints (SMC). Forty-three percent of the patients 
with MDD reported SMC assessed through a single question (Mowla 
et al., 2007). In another study, as much as 70% of the patients with MDD 
endorsed specific cognitive complaint themes (Miebach et al., 2017). 
For sure, SMC are not specific of MDD. To start with, SMC are 
frequently reported by healthy adults (Ponds et al., 1997; Ginó et al., 
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2010; Vlachos et al., 2019) as well as by people in the community who 
seek for primary clinical care (Waldorff et al., 2012). The association of 
SMC with depressive symptoms has been extensively documented in 
young and middle-aged individuals as well as in healthy elders (Jonker 
et al., 2000; Mendes et al., 2008; Balash et al., 2013). From another point 
of view, SMC may represent an important clinical symptom signalling an 
impending neurodegenerative disorder, namely Alzheimer’s disease 
(AD). The presence of SMC may predict future cognitive decline (Reid 
and MacLullich, 2006) and a greater risk to develop dementia (Schmand 
et al., 1996; Mitchell et al., 2014). Recent revised diagnostic criteria that 
incorporate biomarkers maintain the report of memory decline by pa-
tients or informants as part of the core diagnostic features for AD 
(Dubois et al., 2007; Albert et al., 2011). Subjective memory complaints 
thus represent an important, albeit rather non-specific, symptom in 
clinical practice. 
The SMC have been extensively studied in the context of AD and 
other neurodegenerative disorders, but less is known about the char-
acteristics of SMC in patients with MDD. It was suggested that patients 
with MDD might report complaints qualitatively different from other 
disorders, namely expressing more attentional fluctuation and a stron-
ger affective influence on memory (Miebach et al., 2017). In the present 
study, we used the SMC scale (SMCS), an instrument that comprises 
items representative of common memory complaints (Schmand et al., 
1996) to characterize SMC in patients with MDD. 
The relationship between the SMC and objective memory func-
tioning has also raised a lot of interest. Patients with depression (most 
with MDD) and memory complaints indeed performed worse on objec-
tive memory tests as compared to depressed patients without memory 
complaints (Antikainen et al., 2001). However, Lahr et al. (2007) 
observed that patients with MDD reported cognitive problems in their 
everyday life that clearly exceed the deficits in the neuropsychological 
testing. The discrepancy between the report of cognitive problems in 
everyday life and impairment in neuropsychological tests might be 
attributed to increased distractibility to emotionally relevant stimuli 
present in the real world (Beblo et al. 2010). On the other hand, patients 
with MDD may exaggerate the memory complaints in relation to their 
objective memory performance, due to a negative cognitive bias and 
subsequent enhancement of the subjective sense of failure (Farrin et al. 
2003). It is interesting that an opposite pattern might be observed in 
patients at early phases of AD, who have pronounced objective memory 
deficits, and nevertheless may state a relatively favourable opinion 
about their cognitive capabilities reflecting anosognosia, that is, the loss 
of self-knowledge about cognitive deficits (Silva et al., 2014; Ryals et al., 
2018). 
In the present study, we investigated the SMC in patients with MDD. 
We aimed to know 1) the frequency of SMC; 2) the characteristics of 
SMC; 3) the relationship between SMC and objective memory perfor-
mance in patients with MDD, in comparison with patients with early AD 
(MCI due to AD) and healthy controls (HC). We hypothesized that pa-
tients with MDD, by reporting SMC disproportionate to the objective 
memory performance, may show inaccurate memory self-awareness. 
2. Methods 
2.1. Participants 
Participants were recruited in three distinct settings, all in the Lisbon 
area. Patients with MDD were followed at the outpatient clinic at the 
Department of Psychiatry and Mental Health, Centro Hospitalar Uni-
versitário de Lisboa Norte. Patients with aMCI-AD attended a memory 
clinic, Memoclínica. All patients were referred for and completed a 
comprehensive neuropsychological assessment, including the SMCS. HC 
were recruited at leisure centres, in the Lisbon area, that offer recrea-
tional, educational and well-being activities for senior people. The 
present study was conducted according to the declaration of Helsinki 
and was approved by the local ethics committee, the participants’ 
informed consent was obtained before any procedure. 
2.1.1. Inclusion criteria 
2.1.1.1. Major Depressive Disorder. The diagnosis of MDD was estab-
lished according to the Diagnostic and Statistical Manual of Mental 
Disorders (4th ed. Text rev. [DSM-IV-TR]; American Psychiatric Asso-
ciation, 2000). 
The diagnosis of MDD was based on the patient’s medical clinical 
records. An interview with the assistant psychiatrist was conducted to 
confirm the diagnosis and the medications prescribed at the time of the 
neuropsychological assessment, as well as clinical stability criteria, 
namely mood stabilization and no changes in medication in the three 
months prior to the neuropsychological assessment. Only outpatients 
clinically able to undergo through neuropsychological testing were 
included. 
2.1.1.2. Mild Cognitive Impairment due to Alzheimer’s disease. The 
diagnosis of MCI due to AD - high likelihood followed the criteria of the 
National Institute on Aging – Alzheimer’s Association workgroups (Al-
bert et al., 2011). 
The diagnosis of MCI due to AD was established by an experienced 
neurologist (AdeM), after multidisciplinary consensus using all available 
clinical information. 
2.1.1.3. Healthy controls. HC presented no cognitive complaints, 
maintained objective cognitive function and had preserved daily life 
independence. 
2.1.2. Exclusion criteria for all groups 
Presence of neurological disorders, namely stroke, brain tumor, 
significant head trauma, epilepsy; psychiatric disorders, namely MDD 
(except in the MDD group), schizophrenia and bipolar disorder; systemic 
illness with cognitive impact; history of alcohol abuse or recurrent 
substance abuse or dependence; seriously reduced vision or other sen-
sory deficits likely to hinder assessment; presence of dementia according 
to the DSM-IV-TR or abnormal MMSE scores for the Portuguese 
population. 
Detailed inclusion and exclusion criteria for all groups are described 
on supplementary material file. 
2.2. Measures 
2.2.1. Neuropsychological assessment 
A comprehensive neuropsychological assessment was performed by 
the same group of trained neuropsychologists in each institution. The 
neuropsychological battery lasted from 45 to 60 min to be completed 
and comprised the following instruments:  
1) Mini-Mental State Examination (MMSE) (Folstein et al. 1975). 
Normal values for the Portuguese population are >27 for more than 
11 years of education and >22 for 11 or less years of education 
(Guerreiro et al., 1994).  
2) Tests from the Battery of Lisbon for the Assessment of Dementia 
(Garcia, 1984; Guerreiro, 1998). This is a comprehensive neuro-
psychological battery, including tests from the Wechsler Memory 
Scale (Wechsler, 1945) and has been validated for the Portuguese 
population.  
3) Geriatric Depression Scale (GDS; Yesavage et al., 1983; Sheik and 
Yesavage, 1986). The GDS is a self-report questionnaire that evalu-
ates the existence of depressive symptomatology. For the present 
study, we used the short-form (15 items) of the self-report instru-
ment, adapted for the Portuguese population (Barreto et al., 2008). 
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4) Instrumental Activities of Daily Living (IADL; Lawton and Brody, 
1969). The IADL is a tool that evaluates daily self-care activities. The 
Portuguese version was used (Pantoni et al., 2005). 
2.2.2. Subjective memory assessment 
The Subjective Memory Complaints Scale (SMCS) was used 
(Schmand et al., 1996). This scale comprises 10 individual items con-
cerning difficulties in daily life memory tasks, considered representative 
of common memory complaints. Total scores range from 0 (absence of 
complaints) to 21 (maximal complaints score). The Portuguese version 
was used (Ginó et al., 2008). All participants completed the SMCS prior 
to the neuropsychological assessment. 
2.2.3. Estimate of memory awareness 
To study memory awareness in patients with MDD, patients with 
MCI-AD and HC, an index of discrepancy was calculated according to the 
formula [discrepancy score = LM delayed recall (z score) minus − 1* 
SMCS total (z score)], following Vannini et al. (2017). The SMCS was 
multiplied by − 1 because in SMCS a higher score means more memory 
complaints, whereas in the instrument used by Vannini et al. (2017), the 
Memory Functioning Questionnaire, a higher score corresponds to the 
absence of memory problems. In this way, the meaning of the discrep-
ancy score is maintained according to the literature, that is, a lower 
score indicates over-estimation of memory functioning (these in-
dividuals believe they are functioning at a higher level than their 
objective memory performance would suggest), whereas a higher score 
indicates under-estimation of memory functioning (these individuals 
believe they are functioning less well than their objective performance 
would suggest) (Vannini et al., 2017). 
2.3. Statistical analysis 
Statistical analysis was performed using the IBM SPSS Statistics 26 
for Windows (IBM Corp., Armonk, NY) package. The statistical signifi-
cance threshold for all analyses was set at p < 0.05. 
Sample size was a priori estimated from a power analysis using the 
Power and Precision software (v.4; BioStat; Englewood, NJ). Using a 
one-way ANOVA model, recruitment of 45 participants in each group 
would allow detection of a medium size effect (f = 0.25) with power =
73%, and α = 0.05. 
The z scores for all neuropsychological variables, as well as for the 
SMCS with the purpose of obtaining discrepancy scores, were calculated 
according to the age and education norms for the Portuguese population 
with the equation [z=(x-mean)/SD]. 
Data were checked for normality using the Shapiro-Wilk test and for 
homogeneity of variances using the Levene test. Since deviation from 
the normal distribution or the presence of heteroscedasticity were found 
for several variables, the non-parametric Kruskal-Wallis test, followed 
by the post hoc Dunn test, was used to assess differences in demographic, 
clinical and neuropsychological numeric data, discrepancy scores and 
SMCS scores. The analysis of the SMCS 10 items subscores was consid-
ered exploratory, and thus no correction for multiple comparisons being 
performed. When applicable, estimates of effect sizes were calculated 
using the η2 test as described by Tomczak and Tomczak (2014). For 
categorical data Pearson χ2 tests were used followed by the post hoc Z2 
test for comparison of column proportions. 
To know whether the 3 groups of participants could be statistically 
separated according to Logical Memory delayed recall (z score) values 
and the total SMCS (z score) values, a non-hierarchical clustering model 
was applied. The model used the Ward’s Method with squared Euclidean 
distances, imposing a priori 3 clusters. The global percentage of correct 
classifications obtained with the clustering model was compared to the 
global percentage of correct classifications expected by chance alone. A 
model with 25% more correct classifications than the percentage ex-
pected by chance alone is considered to have good classificatory prop-
erties (Marôco, 2011). 
To study the correlations between LM delayed recall, SMC total, 
discrepancy scores and relevant demographic and clinical variables, the 
bivariate Pearson correlation test was performed. 
3. Results 
3.1. Demographic and neuropsychological data 
The study recruited 135 participants (MDD, n = 47; MCI-AD, n = 43; 
HC, n = 45). The demographic and clinical characteristics are shown in 
Table 1. Patients with MDD were younger and more often female when 
compared to the MCI-AD and HC. Both patients with MDD and HC were 
less educated than patients with MCI-AD. Patients with MCI-AD had 
lower MMSE score as compared to the other groups. 
3.2. Neuropsychological assessment 
The results of the comprehensive neuropsychological assessment are 
shown in Table 2. As expected, patients with MCI-AD had poorer per-
formances in tests of memory (Word Recall and Logical Memory im-
mediate and delayed recall) and orientation, as well as verbal initiative 
(Semantic Verbal Fluency). Patients with MDD performed worse in a test 
of attention (Digit Span Forward). 
3.3. Subjective memory complaints 
Patients with MDD (12.5 ± 4.4) and patients with MCI-AD (10.9 ±
4.1) had high and not significantly different SMCS total scores, whereas 
HC had significantly lower scores (4.0 ± 3.0) (Table 3). As much as 
74.5% of patients with MDD patients and 65.1% of patients with MCI- 
AD reported prominent memory complaints (SMCS total z score above 
1.5 according to age and education norms), whereas only 4.4% of HC 
did. An exploratory analysis of the SMCS individual items was per-
formed. Patients scored higher than HC in all items, except item 7, Did 
you ever lose your way in the neighborhood?, a seldom reported complaint. 
Patients with MDD had higher scores than patients with MCI-AD in three 
SMCS items. 
3.4. Awareness of memory 
Awareness of memory functioning was assessed by calculating an 
index based on discrepancy scores between objective memory perfor-
mance (Logical Memory delayed recall, z score) and subjective memory 
report (SMCS total, z score). Patients with MDD showed higher 
discrepancy scores than both patients with MCI-AD and HC, which did 
not significantly differ (Fig. 1). Similar results were obtained when 
calculating the discrepancy scores as the difference between the z scores 
of Word Recall and SMCS (results not shown). 
To understand better this discrepancy between objective perfor-
mance and subjective memory report, the Logical Memory delayed 
recall (z score) values and the total SMCS (z score) values were plotted in 
a Cartesian graph, where the 3 groups of participants appear segregated 
(Fig. 2). In fact, an unsupervised clustering procedure classified 71.1% 
of the cases coincidently with the 3 groups of participants, whereas the 
expected percentage of correct classifications obtained by chance would 
be only 33.4%. HC had good memory performance and few SMC, pa-
tients with MCI-AD showed poor memory performance and many SMC, 
and patients with MDD also reported many SMC but had better memory 
performance than patients with MCI-AD. 
3.5. Correlations between demographic characteristics, SMCS and 
neuropsychological data 
There were no significant correlations between age and education 
with the main variables of interest of the present study, namely, Logical 
Memory delayed recall score, SMCS total score, and the discrepancy 
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score (Table 4). 
The SMCS total score correlated positively with the depressive 
symptoms evaluated by GDS in the three groups, that is, participants 
with depressive symptoms generally reported more SMC (Table 4). This 
correlation might also have driven the correlation between GDS and the 
discrepancy score, of which the SMCS total score is component, and in a 
similar manner the Logical Memory delayed recall score appeared 
correlated with the discrepancy score, of which it is the other 
component. 
4. Discussion 
The main findings of the present study are that patients with MDD 
frequently and heavily report SMC, however they have relatively pre-
served memory tests, resulting in discrepancy between subjective 
memory complaints and objective memory performance. In other words, 
patients with MDD show inaccurate memory self-awareness because 
they under-estimate their memory functioning. 
It might be the prominent SMC in patients with MDD have been 
accentuated by a referral bias, and would not be generalizable, in the 
sense that patients with MDD followed at the outpatient clinic might 
have been referred for comprehensive neuropsychological assessment 
because of more pronounced cognitive complaints. However, the pre-
sent results are consistent with the high frequency of SMC in patients 
with MDD reported in previous studies, as much as 70% of the patients 
with MDD endorsing specific cognitive complaint themes (Miebach 
et al., 2017). Admittedly, the frequency of SMC may depend on whether 
a single question or a full questionnaire is used to elicit the report of 
SMC, as well as on the choice of different questionnaires (Vogel et al., 
2016). 
The profile of SMC in patients with MDD was not very different from 
those reported by patients with MCI-AD. Patients with MDD would score 
even higher than patients with MCI-AD in a few individual SMCS items, 
like item 4, Do you often forget where things are left and item 10, Do you 
have concentration problems?. It is interesting to note that these indi-
vidual SMCS items might involve not only mnestic but also attentional 
capabilities. The presence of diminished ability to think or concentrate is 
acknowledged in the clinical criteria for MDD (American Psychiatric 
Association, 2000). Beblo et al. (2010) suggested that the discrepancy 
between the report of cognitive problems in everyday life and the 
relative preservation of neuropsychological tests in patients with MDD 
could be attributed to increased distractibility to emotionally relevant 
stimuli present in the real world. A previous study found that attention 
difficulties were the most prominent cognitive symptom reported by 
Table 1 
Demographic and clinical characteristics of patients with MDD, patients with MCI-AD and healthy controls.   
MDD MCI-AD HC Statistical significance 
n = 47 n = 43 n = 45 Statistics p-value Post hoc 
Age at first assessment, years, mean (SD) 59.3 (8.7) 68.5 (7.0) 65.9 (8.2) H = 27.591 <0.001 MDD < MCI-AD, HC 
Gender, male/female, n (% female) 7/40 (85) 15/28 (65) 24/21 (47) χ2 = 15.140 0.001 MDD > MCI-AD, HC* 
Education, years, mean (SD) 7.8 (4.7) 12.7 (3.6) 7.6 (5.0) H = 29.978 <0.001 HC, MDD < MCI-AD 
MMSE, mean (SD) 28.4 (1.0) 26.3 (1.9) 28.9 (1.3) H = 42.550 <0.001 MCI-AD < MDD, HC 
GDS, mean (SD) 9.4 (3.5) 4.2 (2.8) 2.5 (2.6) H = 52.236 <0.001 HC < MCI-AD < MDD 
Medication, n (%) 
Antidepressants 40 (85.1) 18 (41.9)     
Mood stabilizers 5 (10.6)      
Antipsychotics 6 (12.8) 1 (2.3)     
Benzodiazepines 34 (72.3) 9 (20.9)     
Acetylcholinesterase inhibitors  9 (20.9)     
Memantine  1 (2.3)     
Abbreviations: MDD = Major Depressive Disorder; MCI-AD = Mild Cognitive Impairment due to Alzheimer’s Disease; HC=Healthy Controls; MMSE = Mini-Mental 
State Examination; GDS = Geriatric Depression Scale; SD = standard deviation. 
H, Kruskal-Wallis test, followed by post hoc Dunn test; *, Pearson’s χ2 test followed by Z2 test for comparison of column proportions, patients with MDD were more 
often females compared to patients with MCI-AD and healthy controls. Statistically significant values (p < 0.05) in bold. 
Medication prescribed at the time of the neuropsychological assessment. MDD patients were not taking acetylcholinesterase inhibitors or memantine. HC participants 
were not taking antidepressants, antipsychotic drugs, acetylcholinesterase inhibitors or memantine. 
Table 2 
Neuropsychological performances in patients with MDD, patients with MCI-AD and healthy controls.      
Statistical significance 
Cognitive domains MDD MCI-AD HC Statistics p-value Effect size Post hoc 
Cognitive tests n = 47 n = 43 n = 45 H  η2  
Attention and Executive functions 
Digit Span Forward − 0.16 (1.22) 0.86 (1.40) 1.85 (1.53) 39.80 <0.001 0.29 MDD < MCI-AD < HC 
Digit Span Backward − 0.02 (1.60) 0.08 (0.90) 0.88 (2.03) 4.68 0.096 0.02 NS 
Verbal Initiative 
Semantic Verbal Fluency 0.62 (1.54) − 0.52 (1.76) 0.35 (1.22) 11.16 0.004 0.07 MCI-AD < MDD, HC 
Reasoning 
Raven CPM 0.08 (0.92) − 0.30 (1.35) 0.50 (0.80) 7.24 0.027 0.04 MCI-AD < HC 
Memory 
Word Recall 0.52 (1.12) − 2.06 (1.57) − 0.36 (1.10) 56.70 <0.001 0.41 MCI-AD < HC < MDD 
Logical Memory (immediate recall) − 0.60 (1.07) − 1.63 (1.12) 0.35 (0.81) 51.92 <0.001 0.38 MCI-AD < MDD < HC 
Logical Memory (delayed recall) − 0.58 (0.99) − 1.55 (1.10) 0.55 (0.64) 64.20 <0.001 0.47 MCI-AD < MDD < HC 
Orientation − 0.38 (2.03) − 5.13 (4.35) 0.43 (0.16) 58.55 <0.001 0.43 MCI-AD < MDD, HC 
Abbreviations: MDD = Major Depressive Disorder; MCI-AD = Mild Cognitive Impairment due to Alzheimer’s Disease; HC=Healthy Controls; CPM=Colored Pro-
gressive Matrices; NS=Non-significant. 
The mean (SD) of tests z scores, calculated according to the equation z=(x-mean)/SD, are shown. Group comparisons were performed with the Kruskal-Wallis test, 
followed by post hoc Dunn test. Statistically significant values (p < 0.05) in bold. 
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patients with MDD (Srisurapanont et al., 2018). 
In the present study, patients with MDD indeed performed poorly, 
even worse than patients with MCI-AD, in attentional tasks, namely the 
Digit Span Forward. A systematic review and meta-analysis demon-
strated that significant moderate deficits in attention (rapid visual in-
formation processing) and executive functions (spatial working 
memory) and to a lesser extent memory (paired associated learning), 
represent a core and clinically relevant feature of depression that per-
sists beyond symptoms of low mood in patients with MDD (Rock et al., 
2014). A meta-analysis concluded that cognitive deficits in euthymic 
patients with MDD are generally modest, with more pronounced deficits 
in executive functions, particularly inhibitory control (Bora et al., 2012). 
Accordingly, in the present study patients with MDD were not as 
affected as patients with MCI-AD in the domains of memory, orientation, 
verbal fluency and reasoning. Nonetheless, cognitive dysfunction does 
represent a core feature of MDD (DSM-5, American Psychiatric Associ-
ation, 2013; Naguy et al., 2020), and treatment of cognitive deficits 
experienced by patients with MDD may contribute to improve functional 
outcomes (Pan et al., 2019). 
The main finding of the present study is that patients with MDD 
showed a distinctive relationship between SMC and objective memory 
performance. Thus, HC had good memory performance and few SMC, 
patients with MCI-AD showed poor memory performance and many 
SMC, whereas patients with MDD also reported many SMC but had 
better memory performance than patients with MCI-AD. The implica-
tions for awareness of memory functioning, measured by discrepancy 
scores between objective memory scores (Logical Memory delayed 
recall) and subjective memory scores (SMCS), are straightforward. 
Awareness of memory, for different reasons, was quite good in HC, who 
correctly appraised to have good memory, and in patients with MCI-AD, 
who had memory complaints and poor memory performance. In 
contrast, awareness of memory turned out to be quite inadequate in 
patients with MDD, who heavily reported memory complaints in face of 
a relatively preserved memory performance. Importantly, we now show 
that the level of memory awareness is able to distinguish patients with 
Table 3 
Subjective memory complaints in patients with MDD, patients with MCI-AD and 
healthy controls.   
MDD MCI- 
AD 
HC Statistical significance 
n = 47 n = 43 n = 45 H p-value Post 
hoc 
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Abbreviations: SMC=Subjective Memory Complaints; SD = standard deviation; 
MDD = Major Depressive Disorder; MCI-AD = Mild Cognitive Impairment due to 
Alzheimer’s Disease; HC=Healthy Controls; NS = Non significant. 
Scoring of items 1, 3, and 4: 0: no; 1: yes, but no problem; 2: yes, problem; 3: yes, 
serious problem. 
Scoring of items 2 and 5: 0: no; 1: yes, sometimes; 2: yes, often. 
Scoring of items 6 and 7: 0: no; 1: yes. 
Scoring of items 8, 9 and 10: 0: no; 1: yes; 2: yes, serious problem. 
Group comparisons were performed with the Kruskal-Wallis test, followed by 
post hoc Dunn test. 
Statistically significant values (p < 0.05) in bold. 
Fig. 1. Comparison of memory self-awareness in patients with MDD, patients 
with MCI-AD and healthy controls. 
Abbreviations: MDD = Major Depression Disorder; MCI-AD = Mild Cognitive 
Impairment due to Alzheimer’s Disease; HC=Healthy Controls. 
Discrepancy scores between objective memory performance and subjective 
memory complaints (mean and SD) are depicted. Patients with MDD patients 
had higher discrepancy scores than patients with MCI-AD and healthy controls. 
Group comparisons were performed with the Kruskal-Wallis test, followed by 
post hoc Dunn test. *p < 0.05. 
Fig. 2. Cartesian graph of participants in reference to subjective memory report 
and objective memory performance. 
Abbreviations: SMCS=Subjective Memory Complaints scale, z score; Logical 
Memory = Logical Memory delayed recall, z score; MCI-AD = Mild Cognitive 
Impairment due to Alzheimer’s Disease; MDD = Major Depressive Disorder. 
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MDD not only from patients with MCI, as reported by Coutinho et al. 
(2016), but also from HC. It interesting to note that a previous study 
from Vannini and co-workers showed altered memory self-awareness in 
patients with MCI-AD, who would overestimate their memory function 
(Vannini et al., 2017). It is recognized that patients at early phases of AD 
may suffer from anosognosia, that is, the loss of self-knowledge about 
cognitive deficits (Ryals et al., 2018). In the present study, patients with 
MCI-AD appeared to maintain awareness of their memory deficits. At an 
early phase of their neurodegenerative trajectory, patients may be able 
to capture and even overestimate the changes in memory that they are 
experiencing (Vannini et al., 2017), and it is plausible that awareness of 
memory in patients with MCI-AD might vary in different studies 
depending on the inclusion of early or late patients with MCI-AD, or the 
specific tests used for the calculation of the index of awareness. 
The reasons for the discrepancy between subjective memory com-
plaints and objective memory performance in patients with MDD are 
worthwhile debating. Patients with MDD may have a negatively biased 
perception (Beck, 1967), leading to a pessimistic neurocognitive 
appraisal (Mohn and Rund, 2016; Schweizer et al., 2018). Another 
possible explanation may be the characteristic of intrusive and rumi-
native negative thoughts might distract these patients more in their 
everyday life environments than in the context of a comprehensive 
neuropsychological assessment (Petersen et al., 2019). In accordance, 
self-reports of severe memory difficulties in everyday life situations 
clearly surpass objective memory performance in standard laboratory 
settings (Beblo et al., 2017; Schwert et al., 2018). In other words, the 
ecological validity of the neuropsychological assessment tests may not 
capture entirely the difficulties of everyday life tasks (Lahr et al., 2007). 
The feebleness of the association between SMC and objective mem-
ory performance is recognized (Gagnon et al., 1994; Jungwirth et al., 
2004). Accordingly, in the present study no associations between SMC 
and objective memory performance were found in the HC, patients with 
MCI-AD and patients with MDD. The absence of association between 
SMC and objective memory performance in healthy individuals has been 
repeatedly reported (Mendes et al., 2008; Schwert et al., 2018). 
Regarding patients with MCI, SMC were weakly associated with objec-
tive memory performance and more strongly related to mood problems 
(Yates et al., 2017). Also Seo et al. (2017) showed that the association 
between SMC and objective memory is largely mediated by the presence 
of depressive symptoms in patients with prodromal AD. Concerning 
patients with MDD, no associations between SMC and objective cogni-
tive deficits were generally found in different studies (Farrin et al., 2003; 
Mohn and Rund, 2016; Srisurapanont et al., 2017; Schwert et al., 2018). 
The importance of the association between SMC and depressive 
symptoms also merits a word. In the present study, it was consistently 
observed in HC, patients with MCI-AD and patients with MDD. The in-
fluence of depressive symptoms, but not age, gender or education, on the 
SMCS scores in healthy people was previously emphasised (Mendes 
et al., 2008). Also, Schweizer and co-workers showed a relationship 
between depressive symptoms and self-reported memory problems in a 
large healthy population cohort, even when controlling for variations in 
age, cognitive ability and gender (Schweizer et al., 2018). A systematic 
review mentioned depression as one of the most important factors 
associated with SMC (Brigola et al., 2015). In patients with MCI, the 
association of SMC and depressive symptoms has been documented in 
many studies collected in the meta-analysis of Mitchell (2008). Specif-
ically in patients fulfilling criteria for MCI-AD, a recent study confirmed 
the association between SMC and depressive symptoms (Mendes et al., 
2019). In patients with mood disorders, subjective memory is also 
negatively influenced by the presence of depressive symptoms, both in 
bipolar disorder (Miskowiak et al., 2016) and in MDD (Srisurapanont 
et al., 2017; Serra-Blasco et al., 2019). Thus, the relationship between 
SMC and depressive symptoms appears quite consistent in different 
populations evaluated. 
To the best of our knowledge, this is the first study to investigate the 
relationship between SMC and objective cognitive performance when 
comparing at the same time patients with MDD, patients with MCI-AD 
and HC. A few other strengths may be pointed out. First, the assess-
ment of SMC was made through a structured self-report questionnaire 
and the comprehensive neuropsychological evaluation was made by the 
same group of trained neuropsychologists. Second, the diagnosis of MDD 
was made by experienced psychiatrists, and the diagnosis and the 
medication prescribed at the time of the assessment were confirmed 
through contact with the respective assistant psychiatrist. In third place, 
the diagnosis of MCI-AD was made by the same neurologist with large 
experience in neurodegenerative diseases, following international 
criteria based on AD biomarkers. A few limitations must also be recog-
nized. Some unbalance among the groups regarding gender and 
Table 4 
Correlations between LM delayed recall, SMC total, discrepancy score and the demographic and clinical variables.    
LM delayed recall SMCS total Discrepancy score 
r p-value r p-value r p-value 
Age MDD − 0.063 0.674 − 0.130 0.385 0.150 0.315 
MCI-AD 0.170 0.275 − 0.207 0.183 − 0.059 0.705 
HC − 0.137 0.371 0.032 0.837 − 0.048 0.752 
Education MDD 0.164 0.271 0.049 0.744 0.139 0.352 
MCI-AD 0.257 0.096 − 0.028 0.857 1.116 0.457 
HC 0.113 0.462 − 0.162 0.288 − 0.084 0.584 
MMSE MDD 0.025 0.882 0.066 0.698 0.069 0.685 
MCI-AD 0.532 0.001 0.130 0.449 0.395 0.017 
HC 0.430 0.003 − 0.129 0.398 0.125 0.412 
GDS MDD − 0.102 0.567 0.352 0.041 0.210 0.232 
MCI-AD 0.141 0.378 0.529 <0.001 0.463 0.002 
HC − 0.132 0.393 0.546 <0.001 0.426 0.004 
DS Forward MDD 0.148 0.321 − 0.070 0.641 0.027 0.859 
MCI-AD − 0.014 0.929 − 0.031 0.843 − 0.030 0.848 
HC 0.032 0.833 − 0.163 0.285 − 0.130 0.394 
LM delayed recall MDD   − 0.098 0.512 0.504 <0.001 
MCI-AD   0.241 0.120 0.709 <0.001 
HC   − 0.145 0.342 0.433 0.003 
Semantic Verbal Fluency MDD 0.092 0.540 − 0.132 0.377 − 0.061 0.686 
MCI-AD 0.307 0.045 0.238 0.125 0.336 0.027 
HC 0.070 0.649 0.116 0.446 0.146 0.340 
Abbreviations: LM = Logical Memory; SMCS=Subjective memory complaints scale; MMSE = Mini-Mental State Examination; GDS = Geriatric Depression Scale; DS =
Digit Span; Discrepancy score = Logical Memory delayed recall (z score) minus − 1 * Subjective Memory Complaints Scale total (z score); r = Pearson correlation 
coefficient. Statistically significant values (p < 0.05) in bold. 
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education was observed, however this would not influence the results, 
since comparisons were performed with z scores adjusted to age and 
education, and no correlations between these demographic factors and 
either objective memory or SMCS were found in any group. Another 
limitation is that we cannot exclude that some participants with MDD, or 
even HC, might have positive AD biomarkers, eventually at a preclinical 
stage of AD. Still another limitation is the use of medication at the time 
of the neuropsychological assessment in the clinical groups, that would 
be unethical to discontinue. 
In conclusion, patients with MDD show inaccurate memory self- 
awareness because they frequently and heavily report SMC while 
keeping relatively preserved memory tests, in contrast to patients with 
MCI-AD and healthy controls. Differential diagnosis between MDD and 
MCI-AD is a difficulty sometimes faced by clinicians (Coutinho et al., 
2016). Although we found differences in memory awareness between 
the two conditions, it is at present unclear whether memory awareness 
might be clinically useful to discriminate between MDD and MCI-AD. 
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Marôco, J., 2011. Análise Estatística Com O SPSS Statistics. 5. Pero Pinheiro, Portugal.  
Mendes, T., Cardoso, S., Guerreiro, M., Maroco, J., Silva, D., Alves, L., Schmand, B., 
Gerardo, B., Lima, M., Santana, I., de Mendonça, A., 2019. Can subjective memory 
complaints identify Aβ positive and Aβ negative amnestic mild cognitive impairment 
patients? J. Alzheim. Dis. 70, 1103–1111. 
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